Poxviruses replicate their linear genomes by forming concatemers that must be resolved into monomeric units to produce new virions. A viral resolvase cleaves DNA four-way junctions extruded at the concatemer junctions to produce monomeric genomes. This cleavage reaction is required for viral replication, so the resolvase is an attractive target for small molecule inhibitors. To provide a platform for understanding resolvase mechanism and designing inhibitors, we have determined the crystal structure of the canarypox virus (CPV) resolvase. CPV resolvase is dimer of RNase H superfamily domains related to Escherichia coli RuvC, with an active site lined by highly conserved acidic residues that bind metal ions. There are several intriguing structural differences between resolvase and RuvC, and a model of the CPV resolvase⅐Holliday junction complex provides insights into the consequences of these differences, including a plausible explanation for the weak sequence specificity exhibited by the poxvirus enzymes. The model also explains why the poxvirus resolvases are more promiscuous than RuvC, cleaving a variety of branched, bulged, and flap-containing substrates. Based on the unique active site structure observed for CPV resolvase, we have carried out a series of experiments to test divalent ion usage and preferences. We find that the two resolvase metal binding sites have different preferences for Mg 2؉ versus Mn 2؉ . Optimal resolvase activity is maintained with 5 M Mn 2؉ and 100 M Mg 2؉ , concentrations that are well below those required for either metal alone. Together, our findings provide biochemical insights and structural models that will facilitate studying poxvirus replication and the search for efficient poxvirus inhibitors.Poxviruses infect a broad range of vertebrate and invertebrate hosts, including mammals, birds, reptiles, and insects (1). The best known example is variola, the virus responsible for smallpox. Although smallpox has been eradicated, there is still significant interest in poxvirus therapeutics. Part of this interest stems from the potential use of variola as a biological weapon, but other poxvirus strains also cause significant morbidity and mortality even today (2).All poxviruses have long, linear, double-stranded DNA genomes that are replicated in the cytoplasm of infected cells. The vaccinia virus (VV), 3 used for many years as a naturally attenuated vaccine to eliminate smallpox has served as the prototype poxvirus for laboratory research (3). The VV genome is 200 kb in length and encodes ϳ200 genes.During poxvirus replication (Fig. 1), a viral DNA polymerase and several auxiliary factors generate concatemers of the linear genome using a rolling hairpin replication mechanism (1). The concatemer junctions between unit genomes contain inverted repeat sequences that can be extruded as four-way DNA junctions (4). These cruciform structures are cleaved by a viral resolvase, resulting in monomeric genomes that can ultimately be packaged into new virions (5, 6). The VV resolvase (named A22)...